Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML-Reference-Cited by-同舟云学术

Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML

Published:2019-02-13 Issue:4 Volume:102 Page:368-374
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Pasic Ivan¹^ORCID,Da'na Waleed¹,Lam Wilson¹,Law Arjun¹,Lipton Jeffrey H.¹,Viswabandya Auro¹,Kim Dennis D.¹,Thyagu Santhosh¹,Messner Hans A.¹,Michelis Fotios V.¹^ORCID

Affiliation:

1. Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre; University Health Network, University of Toronto; Toronto Ontario Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13216/fullpdf

Reference17 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

2. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia;Schlenk;N Engl J Med,2008

3. Investigation of the freely available easy-to-use software “EZR” for medical statistics;Kanda;Bone Marrow Transplant,2013

4. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group;Krönke;J Clin Oncol,2011

5. Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse;Hubmann;Haematologica,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram to Predict Clinical Outcome in FLT3-ITD Acute Myeloid Leukemia;2024-03-19

2. Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML;International Journal of Hematology;2022-07-20

3. Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation;Cytotherapy;2021-12

4. Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era;BLOOD RESEARCH;2020-12-31

5. Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation;Annals of Hematology;2020-05-07